RB1 Blocking Peptide
Référence MBS822945-5x5mg
Conditionnement : 5x5mg
Marque : MyBiosource
RB1 Blocking Peptide – >85% Purity
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS822945MBS822945 is a blocking peptide targeting RB1. Reactive in Human, Mouse, Rat, Bovine, Dog, Pig. Host: Synthetic. The peptide is used to block Anti-RB1 Antibody reactivity. More details
Product Overview
Online Datasheet in PDFProduct Name
RB1, Blocking Peptide
Full Product Name
RB1 Blocking Peptide
Product Gene Name
RB1 blocking peptide
Product Synonym Names
Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
Host
Synthetic
Species Reactivity
Human, Mouse, Rat, Bovine, Dog, Pig
Form/Format
Lyophilized powder
Purity/Purification
>85%
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Antibody/Peptide Pairs
RB1 peptide (MBS822945) is used for blocking the activity of RB1 antibody (MBS821537)
Molecular Weight
106,159 Da
OMIM
phenotype 614041
Quality Control
The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Applications Tested/Suitable for RB1 blocking peptide
Blocking (BL)
Application Notes for RB1 blocking peptide
Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours.
Other Notes
Small volumes of RB1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for RB1. It may not necessarily be applicable to this product.
NCBI Official Full Name
retinoblastoma-associated protein
NCBI Official Synonym Full Names
retinoblastoma 1
NCBI Official Symbol
RB1
NCBI Official Synonym Symbols
RB; pRb; OSRC; pp110; p105-Rb; PPP1R130
UniProt Protein Name
Retinoblastoma-associated protein
UniProt Synonym Protein Names
p105-Rb; pRb; Rb; pp110
Protein Family
Retinoblastoma-associated protein
UniProt Gene Name
RB1
UniProt Synonym Gene Names
Rb
UniProt Entry Name
RB_HUMAN
NCBI Protein Information
retinoblastoma-associated protein; retinoblastoma suspectibility protein; prepro-retinoblastoma-associated protein; protein phosphatase 1, regulatory subunit 130
NCBI Summary for RB1
The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for RB1
Rb: retinoblastoma tumor suppressor protein regulates cell proliferation by controlling progression through the G1-phase restriction point. Has three distinct binding domains and interacts with regulatory proteins including the E2F family of transcription factors, c-Abl tyrosine kinase and proteins with a conserved LXCXE motif. Cell cycle-dependent phosphorylation by Cdks inhibits Rb target binding, thus allowing cell cycle progression. Recruits and targets histone methyltransferase suv39h1 leading to epigenetic transcriptional repression.
Protein type: Tumor suppressor; Transcription, coactivator/corepressor; Oncoprotein; Nuclear receptor co-regulator
Chromosomal Location of Human Ortholog: 13q14.2
Cellular Component: nucleoplasm; SWI/SNF complex; Rb-E2F complex; PML body; spindle; chromatin; nucleus
Molecular Function: identical protein binding; protein binding; androgen receptor binding; DNA binding; ubiquitin protein ligase binding; transcription coactivator activity; phosphoprotein binding; transcription factor activity; transcription factor binding; kinase binding
Biological Process: sister chromatid biorientation; viral reproduction; positive regulation of transcription, DNA-dependent; negative regulation of transcription from RNA polymerase II promoter, mitotic; regulation of mitotic cell cycle; neuron maturation; cell cycle arrest; positive regulation of macrophage differentiation; neurite development; negative regulation of epithelial cell proliferation; transcription, DNA-dependent; mitotic cell cycle checkpoint; negative regulation of transcription factor activity; enucleate erythrocyte differentiation; regulation of lipid kinase activity; chromatin remodeling; G1/S-specific transcription in mitotic cell cycle; myoblast differentiation; neuron apoptosis; maintenance of mitotic sister chromatid cohesion; gut development; cell division; neuron morphogenesis during differentiation; negative regulation of smoothened signaling pathway; androgen receptor signaling pathway; Ras protein signal transduction; positive regulation of mitotic metaphase/anaphase transition; striated muscle cell differentiation; negative regulation of protein kinase activity; positive regulation of transcription from RNA polymerase II promoter; mitotic cell cycle; negative regulation of transcription, DNA-dependent; cell cycle checkpoint; G1/S transition of mitotic cell cycle
Disease: Bladder Cancer; Osteogenic Sarcoma; Small Cell Cancer Of The Lung; Retinoblastoma
Show more Protein type: Tumor suppressor; Transcription, coactivator/corepressor; Oncoprotein; Nuclear receptor co-regulator
Chromosomal Location of Human Ortholog: 13q14.2
Cellular Component: nucleoplasm; SWI/SNF complex; Rb-E2F complex; PML body; spindle; chromatin; nucleus
Molecular Function: identical protein binding; protein binding; androgen receptor binding; DNA binding; ubiquitin protein ligase binding; transcription coactivator activity; phosphoprotein binding; transcription factor activity; transcription factor binding; kinase binding
Biological Process: sister chromatid biorientation; viral reproduction; positive regulation of transcription, DNA-dependent; negative regulation of transcription from RNA polymerase II promoter, mitotic; regulation of mitotic cell cycle; neuron maturation; cell cycle arrest; positive regulation of macrophage differentiation; neurite development; negative regulation of epithelial cell proliferation; transcription, DNA-dependent; mitotic cell cycle checkpoint; negative regulation of transcription factor activity; enucleate erythrocyte differentiation; regulation of lipid kinase activity; chromatin remodeling; G1/S-specific transcription in mitotic cell cycle; myoblast differentiation; neuron apoptosis; maintenance of mitotic sister chromatid cohesion; gut development; cell division; neuron morphogenesis during differentiation; negative regulation of smoothened signaling pathway; androgen receptor signaling pathway; Ras protein signal transduction; positive regulation of mitotic metaphase/anaphase transition; striated muscle cell differentiation; negative regulation of protein kinase activity; positive regulation of transcription from RNA polymerase II promoter; mitotic cell cycle; negative regulation of transcription, DNA-dependent; cell cycle checkpoint; G1/S transition of mitotic cell cycle
Disease: Bladder Cancer; Osteogenic Sarcoma; Small Cell Cancer Of The Lung; Retinoblastoma
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with RB1 blocking peptide
| Reference Product | PubMed Publications |
|---|---|
| CCND1 blocking peptide | >107 publications with RB1 and CCND1 |
| CDK4 blocking peptide | >79 publications with RB1 and CDK4 |
| MDM2 blocking peptide | >65 publications with RB1 and MDM2 |
| E2F1 blocking peptide | >49 publications with RB1 and E2F1 |
| E2F3 blocking peptide | >21 publications with RB1 and E2F3 |
| CDK2 blocking peptide | >19 publications with RB1 and CDK2 |
| CCNE1 blocking peptide | >10 publications with RB1 and CCNE1 |
| HDAC1 blocking peptide | >6 publications with RB1 and HDAC1 |
| RBBP4 blocking peptide | >3 publications with RB1 and RBBP4 |
Pathways associated with RB1 blocking peptide
| Products by Pathway | Pathway Diagram |
|---|---|
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| Androgen Receptor Signaling Pathway antibodies | Androgen Receptor Signaling Pathway Diagram |
| B Cell Receptor Signaling Pathway antibodies | B Cell Receptor Signaling Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Cell Cycle Pathway antibodies | Cell Cycle Pathway Diagram |
| Cell Cycle, Mitotic Pathway antibodies | Cell Cycle, Mitotic Pathway Diagram |
| Cell Cycle Pathway antibodies | Cell Cycle Pathway Diagram |
| Cell Cycle Pathway antibodies | Cell Cycle Pathway Diagram |
| Cell Cycle Pathway antibodies | Cell Cycle Pathway Diagram |
Diseases associated with RB1 blocking peptide
| Disease Name | Pubmed Publications |
|---|---|
| Retinoblastoma Antibodies | >1087 publications with RB1 and Retinoblastoma |
| Carcinoma Antibodies | >295 publications with RB1 and Carcinoma |
| Breast Neoplasms Antibodies | >124 publications with RB1 and Breast Neoplasms |
| Adenocarcinoma Antibodies | >120 publications with RB1 and Adenocarcinoma |
| Lung Neoplasms Antibodies | >89 publications with RB1 and Lung Neoplasms |
| Neoplasms, Experimental Antibodies | >82 publications with RB1 and Neoplasms, Experimental |
| Osteosarcoma Antibodies | >75 publications with RB1 and Osteosarcoma |
| Liver Diseases Antibodies | >56 publications with RB1 and Liver Diseases |
| Liver Neoplasms Antibodies | >47 publications with RB1 and Liver Neoplasms |
| Necrosis Antibodies | >47 publications with RB1 and Necrosis |
Organs/Tissues associated with RB1 blocking peptide
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >307 publications with RB1 and Blood |
| Eye Antibodies | >230 publications with RB1 and Eye |
| Brain Antibodies | >208 publications with RB1 and Brain |
| Lung Antibodies | >139 publications with RB1 and Lung |
| Bone Antibodies | >108 publications with RB1 and Bone |
| Liver Antibodies | >105 publications with RB1 and Liver |
| Muscle Antibodies | >86 publications with RB1 and Muscle |
| Skin Antibodies | >61 publications with RB1 and Skin |
| Intestine Antibodies | >58 publications with RB1 and Intestine |
| Prostate Antibodies | >55 publications with RB1 and Prostate |


